Home > Authorities > Grants > Record #149562 > print

001     149562
005     20230208173435.0
024 7 _ |a G:(EU-Grant)675265
|d 675265
|2 CORDIS
024 7 _ |a G:(EU-Call)H2020-MSCA-ITN-2015
|d H2020-MSCA-ITN-2015
|2 CORDIS
024 7 _ |a corda__h2020::675265
|2 originalID
035 _ _ |a G:(EU-Grant)675265
150 _ _ |a Optimization of Medical Accelerators
|y 2016-02-01 - 2020-01-31
371 _ _ |a LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
|b LMU MUENCHEN
|d Germany
|e http://www.uni-muenchen.de
|v CORDIS
371 _ _ |a CERN
|b CERN
|d Switzerland
|e https://home.cern/
|v CORDIS
371 _ _ |a AMSTERDAM SCIENTIFIC INSTRUMENTS BV
|d Netherlands
|e http://www.amscins.com
|v CORDIS
371 _ _ |a Paul Scherrer Institute
|b PSI
|d Switzerland
|e http://www.psi.ch/
|v CORDIS
371 _ _ |a University of London - University College London
|b UCL
|d United Kingdom
|e http://www.ucl.ac.uk/
|v CORDIS
371 _ _ |a VIALUX MESSTECHNIK + BILDVERARBEITUNG GMBH
|b VIALUX
|d Germany
|e http://www.vialux.de
|v CORDIS
371 _ _ |a Ion Beam Applications (Belgium)
|b Ion Beam Applications (Belgium)
|d Belgium
|v CORDIS
371 _ _ |a FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICA
|b CNAO
|d Italy
|e http://www.cnao.it/
|v CORDIS
371 _ _ |a AGENCIA ESTATAL CONSEJO SUPERIOR DEINVESTIGACIONES CIENTIFICAS
|b CSIC
|d Spain
|e http://www.csic.es
|v CORDIS
371 _ _ |a University of Seville
|b University of Seville
|d Spain
|e http://www.us.es/eng
|v CORDIS
371 _ _ |a EBG (Entwicklungs- und Betriebsgesellschaft) MedAustron GmbH
|d Austria
|e http://www.medaustron.at
|v CORDIS
371 _ _ |a University of Manchester
|b University of Manchester
|d United Kingdom
|e http://www.manchester.ac.uk/
|v CORDIS
371 _ _ |a University of Liverpool
|b University of Liverpool
|d United Kingdom
|e http://www.liv.ac.uk/
|v CORDIS
371 _ _ |a GSI Helmholtzzentrum für Schwerionenforschung GmbH
|b GSI
|d Germany
|e http://www.gsi.de/
|v CORDIS
372 _ _ |a H2020-MSCA-ITN-2015
|s 2016-02-01
|t 2020-01-31
450 _ _ |a OMA
|w d
|y 2016-02-01 - 2020-01-31
510 1 _ |0 I:(DE-588b)5098525-5
|a European Union
|2 CORDIS
680 _ _ |a Cancer is a major social problem, and it is the main cause of death between the ages 45-65 years. In the treatment of cancer, radio therapy (RT) plays an essential role. RT with hadrons (protons and light ions), due to their unique physical and radiobiological properties, offers several advantages over photons for specific cancer types. In particular, they penetrate the patient with minimal diffusion, they deposit maximum energy at the end of their range, and they can be shaped as narrow focused and scanned pencil beams of variable penetration depth. Although significant progress has been made in the use of particle beams for cancer treatment, an extensive research and development program is still needed to maximize the healthcare benefits from these therapies. The Optimization of Medical Accelerators (OMA) is the aim of the here-proposed European Training Network, in line with the requirements of the EC’s Medical Exposure Directive. OMA joins universities, research centers and clinical facilities with industry partners to address the challenges in treatment facility design and optimization, numerical simulations for the development of advanced treatment schemes, and in beam imaging and treatment monitoring. The proposed R&D program ranges from life sciences (oncology, cell and micro biology and medical imaging.), physics and accelerator sciences, mathematics and IT, to engineering. It is hence ideally suited for an innovative training of early stage researchers. By closely linking all above research areas, OMA will provide an interdisciplinary education to its Fellows. This will equip them with solid knowledge also in research areas adjacent to their core research field, as well as with business competences and hence give them a perfect basis for a career in research.
909 C O |o oai:juser.fz-juelich.de:243800
|p authority:GRANT
|p authority
909 C O |o oai:juser.fz-juelich.de:243800
970 _ _ |a oai:dnet:corda__h2020::285a7ca22db6482c418d58014a6cc1a2
980 _ _ |a G
980 _ _ |a CORDIS
980 _ _ |a AUTHORITY

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21